BioSpace News Archive

On June 15, the second Chengdu International Cosmetic Medicine Industry Conference and the “Capital of Cosmetic Medicine” summit forum, cosponsored by Chengdu People’s Government, Sichuan Health Committee, and Chinese Association of Plastics and Aesthetics, officially opened at International Convention Center, Century City, Chengdu, and the conference will last till June 17.

Québec Inc., has received a notification letter from Health Canada indicating that all requested license amendments have been approved.

Policy Statement Reviewed & Supported by the American Camp Association

Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term

Ovation is a leading provider of fertility laboratory services, including in-vitro fertilization laboratory services, genetic testing, egg & embryo storage and other services for the fertility industry.

The Conference will explore the latest developments in the European market.

Juventas will continue to develop CNCT19 with CASI’s participation on the program’s steering committee.

David Liu, Ph.D., Chief Scientific Officer and Head of Research and Development, will provide a corporate overview at the BMO 2019 Prescription for Success Healthcare Conference in New York.

Phase I Clinical Trial of anti-CD20 Chimeric Antigen Receptor T-cell targeting anti-CD19 treated, relapsed diffuse large B-cell lymphoma and small B-cell lymphoma patients in China, and dosed the first CD19 CAR-T relapsed DLBCL patient.

Choom Niagara, the first legal, adult use cannabis store to operate in Niagara Falls, ON has produced over $49,000 in sales on its opening day.